相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Tumor targeting via EPR: Strategies to enhance patient responses
Susanne K. Golombek et al.
ADVANCED DRUG DELIVERY REVIEWS (2018)
PD-1 Blockade Cellular Vesicles for Cancer Immunotherapy
Xudong Zhang et al.
ADVANCED MATERIALS (2018)
Persistence With Immunomodulator Monotherapy Use And Incidence of Therapeutic Ineffectiveness Among Users of Immunomodulator Monotherapy in IBD
Laura E. Targownik et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2018)
Pre-adsorption of antibodies enables targeting of nanocarriers despite a biomolecular corona
Manuel Tonigold et al.
NATURE NANOTECHNOLOGY (2018)
Expansion of allogeneic NK cells with efficient antibody-dependent cell cytotoxicity against multiple tumors
Diego Sanchez-Martinez et al.
THERANOSTICS (2018)
Bioinspired Artificial Nanodecoys for Hepatitis B Virus
Xuan Liu et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2018)
Clinical translation of immunoliposomes for cancer therapy: recent perspectives
Di Wang et al.
EXPERT OPINION ON DRUG DELIVERY (2018)
Genetically Engineered Liposome-like Nanovesicles as Active Targeted Transport Platform
Pengfei Zhang et al.
ADVANCED MATERIALS (2018)
Aptamer-Conjugated Extracellular Nanovesicles for Targeted Drug Delivery
Yuan Wan et al.
CANCER RESEARCH (2018)
Immune targets and neoantigens for cancer immunotherapy and precision medicine
Rong-Fu Wang et al.
CELL RESEARCH (2017)
Antibody-dependent cell cytotoxicity: immunotherapy strategies enhancing effector NK cells
Maria Carmen Ochoa et al.
IMMUNOLOGY AND CELL BIOLOGY (2017)
Exosomes facilitate therapeutic targeting of oncogenic KRAS in pancreatic cancer
Sushrut Kamerkar et al.
NATURE (2017)
Strategies and challenges for the next generation of antibody drug conjugates
Alain Beck et al.
NATURE REVIEWS DRUG DISCOVERY (2017)
Reporter gene imaging of targeted T cell immunotherapy in recurrent glioma
Khun Visith Keu et al.
SCIENCE TRANSLATIONAL MEDICINE (2017)
An anti-glypican 3/CD3 bispecific T cell-redirecting antibody for treatment of solid tumors
Takahiro Ishiguro et al.
SCIENCE TRANSLATIONAL MEDICINE (2017)
Exosomes in Cancer Nanomedicine and Immunotherapy: Prospects and Challenges
Nicholas L. Syn et al.
TRENDS IN BIOTECHNOLOGY (2017)
Prospects for combining targeted and conventional cancer therapy with immunotherapy
Philip Gotwals et al.
NATURE REVIEWS CANCER (2017)
Re-Engineering Extracellular Vesicles as Smart Nanoscale Therapeutics
James P. K. Armstrong et al.
ACS NANO (2017)
Cancer Cell Membrane-Biomimetic Nanoparticles for Homologous-Targeting Dual-Modal Imaging and Photothermal Therapy
Ze Chen et al.
ACS NANO (2016)
DRUG DELIVERY Nanoparticles improve profile of molecularly targeted cancer drug
Megan Cully
NATURE REVIEWS DRUG DISCOVERY (2016)
Development of immuno-oncology drugs - from CTLA4 to PD1 to the next generations
Axel Hoos
NATURE REVIEWS DRUG DISCOVERY (2016)
Prospective Evaluation of Cetuximab-Mediated Antibody-Dependent Cell Cytotoxicity in Metastatic Colorectal Cancer Patients Predicts Treatment Efficacy
Anna Maria Trotta et al.
CANCER IMMUNOLOGY RESEARCH (2016)
Acquired resistance to immunotherapy and future challenges
Nicholas P. Restifo et al.
NATURE REVIEWS CANCER (2016)
Dually pH/Reduction-Responsive Vesicles for Ultrahigh-Contrast Fluorescence Imaging and Thermo-Chemotherapy-Synergized Tumor Ablation
Aijun Zhu et al.
ACS NANO (2015)
Anticancer Platelet-Mimicking Nanovehicles
Quanyin Hu et al.
ADVANCED MATERIALS (2015)
Smart Albumin-Biomineralized Nanocomposites for Multimodal Imaging and Photothermal Tumor Ablation
Yong Wang et al.
ADVANCED MATERIALS (2015)
Passively Acquired Antibody-Dependent Cellular Cytotoxicity (ADCC) Activity in HIV-Infected Infants Is Associated with Reduced Mortality
Caitlin Milligan et al.
CELL HOST & MICROBE (2015)
Ferritin: A Versatile Building Block for Bionanotechnology
Guenther Jutz et al.
CHEMICAL REVIEWS (2015)
Engineering opportunities in cancer immunotherapy
Laura Jeanbart et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2015)
Evolving synergistic combinations of targeted immunotherapies to combat cancer
Ignacio Melero et al.
NATURE REVIEWS CANCER (2015)
Building better monoclonal antibody-based therapeutics
George J. Weiner
NATURE REVIEWS CANCER (2015)
被撤回的出版物: Targeting CD137 enhances the efficacy of cetuximab (Retracted article. See vol. 129, pg. 2595, 2019)
Holbrook E. Kohrt et al.
JOURNAL OF CLINICAL INVESTIGATION (2014)
Cancer Cell Membrane-Coated Nanoparticles for Anticancer Vaccination and Drug Delivery
Ronnie H. Fang et al.
NANO LETTERS (2014)
Ferritin Nanocages To Encapsulate and Deliver Photosensitizers for Efficient Photodynamic Therapy against Cancer
Zipeng Zhen et al.
ACS NANO (2013)
The EPR effect for macromolecular drug delivery to solid tumors: Improvement of tumor uptake, lowering of systemic toxicity, and distinct tumor imaging in vivo
Hiroshi Maeda et al.
ADVANCED DRUG DELIVERY REVIEWS (2013)
Controlled antibody/(bio-) conjugation of inorganic nanoparticles for targeted delivery
Jose-Maria Montenegro et al.
ADVANCED DRUG DELIVERY REVIEWS (2013)
Nanoparticle-detained toxins for safe and effective vaccination
Che-Ming J. Hu et al.
NATURE NANOTECHNOLOGY (2013)
Antibody-Based Immunotherapy of Cancer
Louis M. Weiner et al.
CELL (2012)
被撤回的出版物: Stimulation of natural killer cells with a CD137-specific antibody enhances trastuzumab efficacy in xenotransplant models of breast cancer (Retracted article. See vol. 129, pg. 2595, 2019)
Holbrook E. Kohrt et al.
JOURNAL OF CLINICAL INVESTIGATION (2012)
DNA Conjugated SWCNTs Enter Endothelial Cells via Rac1 Mediated Macropinocytosis
Santanu Bhattacharya et al.
NANO LETTERS (2012)
The EPR effect: Unique features of tumor blood vessels for drug delivery, factors involved, and limitations and augmentation of the effect
Jun Fang et al.
ADVANCED DRUG DELIVERY REVIEWS (2011)
Generation of a humanized anti-glypican 3 antibody by CDR grafting and stability optimization
Kiyotaka Nakano et al.
ANTI-CANCER DRUGS (2010)
NIR dyes for bioimaging applications
Jorge O. Escobedo et al.
CURRENT OPINION IN CHEMICAL BIOLOGY (2010)
Strategies and challenges for the next generation of therapeutic antibodies
Alain Beck et al.
NATURE REVIEWS IMMUNOLOGY (2010)
Monoclonal antibodies: versatile platforms for cancer immunotherapy
Louis M. Weiner et al.
NATURE REVIEWS IMMUNOLOGY (2010)
Therapeutic antitumor efficacy of monoclonal antibody against Claudin-4 for pancreatic and ovarian cancers
Masayo Suzuki et al.
CANCER SCIENCE (2009)
Anti-Glypican 3 Antibody as a Potential Antitumor Agent for Human Liver Cancer
Takahiro Ishiguro et al.
CANCER RESEARCH (2008)